Cadila Pharmaceuticals (UK) started in year 2000 as Private Limited Company with registration number 04113581. The Cadila Pharmaceuticals (UK) company has been functioning successfully for twenty four years now and its status is active. The firm's office is based in Harrow at Amba House 4th Floor. Postal code: HA1 1BA. Since 2022-11-11 Cadila Pharmaceuticals (UK) Ltd is no longer carrying the name Cadila Pharmaceuticals (europe).
The company has 2 directors, namely Amitabha B., Rajiv M.. Of them, Rajiv M. has been with the company the longest, being appointed on 23 November 2000 and Amitabha B. has been with the company for the least time - from 13 December 2018. At the moment there are several former directors listed by the company. Their names might be found in the box below. In addition, there is one former secretary - Bhavana K. who worked with the the company until 15 October 2010.
Office Address | Amba House 4th Floor |
Office Address2 | Kings Suite 15 College Road |
Town | Harrow |
Post code | HA1 1BA |
Country of origin | United Kingdom |
Registration Number | 04113581 |
Date of Incorporation | Thu, 23rd Nov 2000 |
Industry | Management consultancy activities other than financial management |
Industry | Wholesale of pharmaceutical goods |
End of financial Year | 31st March |
Company age | 24 years old |
Account next due date | Sun, 31st Dec 2023 (135 days after) |
Account last made up date | Thu, 31st Mar 2022 |
Next confirmation statement due date | Thu, 7th Dec 2023 (2023-12-07) |
Last confirmation statement dated | Wed, 23rd Nov 2022 |
The register of PSCs who own or have control over the company is made up of 2 names. As BizStats discovered, there is Rajiv M. The abovementioned PSC has 75,01-100% voting rights. The second entity in the persons with significant control register is Shila M. This PSC and has 25-50% voting rights.
Rajiv M.
Notified on | 6 April 2016 |
Nature of control: |
75,01-100% voting rights |
Shila M.
Notified on | 6 April 2016 |
Ceased on | 21 December 2017 |
Nature of control: |
25-50% voting rights |
Cadila Pharmaceuticals (europe) | November 11, 2022 |
Profit & Loss | ||||
---|---|---|---|---|
Accounts Information Date | 2014-03-31 | 2015-03-31 | 2022-03-31 | 2023-03-31 |
Net Worth | 1 205 359 | 2 852 971 | ||
Balance Sheet | ||||
Cash Bank On Hand | 119 804 | 376 692 | ||
Current Assets | 1 275 227 | 558 482 | 330 406 | 910 510 |
Debtors | 413 707 | 236 691 | 210 602 | 533 818 |
Net Assets Liabilities | 2 128 898 | 1 528 803 | ||
Other Debtors | 134 949 | 173 211 | ||
Property Plant Equipment | 3 804 786 | 4 511 317 | ||
Cash Bank In Hand | 861 520 | 321 791 | ||
Net Assets Liabilities Including Pension Asset Liability | 1 205 359 | 2 852 971 | ||
Tangible Fixed Assets | 2 593 813 | |||
Reserves/Capital | ||||
Called Up Share Capital | 1 205 815 | 2 960 986 | ||
Profit Loss Account Reserve | -456 | -108 015 | ||
Shareholder Funds | 1 205 359 | 2 852 971 | ||
Other | ||||
Accrued Liabilities Deferred Income | 33 465 | 9 500 | ||
Accumulated Amortisation Impairment Intangible Assets | 168 831 | 188 224 | ||
Accumulated Depreciation Impairment Property Plant Equipment | 758 579 | 931 474 | ||
Administration Support Average Number Employees | 3 | 3 | ||
Amounts Owed By Group Undertakings Participating Interests | 56 289 | 340 752 | ||
Amounts Owed To Group Undertakings Participating Interests | 1 256 055 | 2 489 486 | ||
Average Number Employees During Period | 7 | 16 | ||
Bank Borrowings Overdrafts | 75 492 | 75 492 | ||
Comprehensive Income Expense | 157 042 | -1 000 095 | ||
Creditors | 1 372 895 | 2 718 838 | ||
Deferred Tax Liabilities | 29 315 | 134 921 | ||
Distribution Average Number Employees | 4 | 13 | ||
Fixed Assets | 4 840 | 2 598 653 | 3 829 882 | 4 517 020 |
Future Minimum Lease Payments Under Non-cancellable Operating Leases | 52 026 | 34 684 | ||
Income Expense Recognised Directly In Equity | 400 000 | |||
Increase Decrease In Existing Provisions | 105 605 | |||
Increase From Amortisation Charge For Year Intangible Assets | 19 393 | |||
Increase From Depreciation Charge For Year Property Plant Equipment | 172 895 | |||
Intangible Assets | 25 096 | 5 703 | ||
Intangible Assets Gross Cost | 193 927 | |||
Issue Equity Instruments | 400 000 | |||
Net Current Assets Liabilities | 1 200 519 | 254 318 | -1 042 489 | -1 808 328 |
Net Deferred Tax Liability Asset | 29 315 | 134 921 | ||
Number Shares Issued Fully Paid | 2 960 986 | 3 360 986 | ||
Other Creditors | 7 883 | 7 441 | ||
Other Taxation Social Security Payable | 136 919 | |||
Pension Other Post-employment Benefit Costs Other Pension Costs | 3 618 | 11 266 | ||
Prepayments Accrued Income | 19 364 | 19 855 | ||
Profit Loss | 157 042 | -1 000 095 | ||
Property Plant Equipment Gross Cost | 4 563 365 | 5 442 791 | ||
Provisions | 29 316 | 134 921 | ||
Provisions For Liabilities Balance Sheet Subtotal | 29 315 | 134 921 | ||
Social Security Costs | 47 557 | 140 131 | ||
Staff Costs Employee Benefits Expense | 379 993 | 1 712 433 | ||
Total Additions Including From Business Combinations Property Plant Equipment | 1 612 445 | |||
Total Assets Less Current Liabilities | 1 205 359 | 2 852 971 | 2 787 393 | 2 708 692 |
Total Increase Decrease From Revaluations Property Plant Equipment | -733 019 | |||
Wages Salaries | 328 818 | 1 561 036 | ||
Advances Credits Directors | 131 702 | |||
Creditors Due Within One Year | 74 708 | 304 164 | ||
Investments Fixed Assets | 4 840 | 4 840 | ||
Number Shares Allotted | 1 205 815 | 2 960 986 | ||
Par Value Share | 1 | |||
Share Capital Allotted Called Up Paid | 1 205 815 | 2 960 986 | ||
Tangible Fixed Assets Additions | 2 663 182 | |||
Tangible Fixed Assets Cost Or Valuation | 2 663 182 | |||
Tangible Fixed Assets Depreciation | 69 369 | |||
Tangible Fixed Assets Depreciation Charged In Period | 69 369 |
Type | Category | Free download | |
---|---|---|---|
AA |
Accounts for a small company made up to 2023-03-31 filed on: 15th, December 2023 |
accounts | Free Download (19 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy